메뉴 건너뛰기




Volumn 37, Issue 1, 2012, Pages

Adverse events associated with switching antipsychotics

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; HALOPERIDOL; HISTAMINE H1 RECEPTOR ANTAGONIST; MUSCARINIC M1 RECEPTOR ANTAGONIST; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; SEROTONIN 2A ANTAGONIST; SUGAR; ZIPRASIDONE;

EID: 84255168904     PISSN: 11804882     EISSN: 14882434     Source Type: Journal    
DOI: 10.1503/jpn.110096     Document Type: Article
Times cited : (10)

References (2)
  • 1
    • 77954166205 scopus 로고    scopus 로고
    • From receptor pharmacology to improved outcomes: Individualising the selection, dosing, and switching of antipsychotics
    • Correll CU. From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics. Eur Psychiatry 2010;25:S12-S21.
    • (2010) Eur Psychiatry , vol.25
    • Correll, C.U.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.